Compare IVVD & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVVD | USNA |
|---|---|---|
| Founded | 2020 | 1992 |
| Country | United States | United States |
| Employees | 100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 437.1M | 382.1M |
| IPO Year | 2021 | 1996 |
| Metric | IVVD | USNA |
|---|---|---|
| Price | $1.55 | $21.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $8.75 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 2.6M | 100.7K |
| Earning Date | 04-11-2026 | 05-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.99 | N/A |
| EPS | N/A | ★ 0.67 |
| Revenue | $25,384,000.00 | ★ $1,060,902,000.00 |
| Revenue This Year | $107.86 | $5.41 |
| Revenue Next Year | $146.53 | $6.12 |
| P/E Ratio | ★ N/A | $32.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $18.48 |
| 52 Week High | $3.07 | $38.32 |
| Indicator | IVVD | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 37.24 | 49.35 |
| Support Level | $1.50 | $18.57 |
| Resistance Level | $1.66 | $22.52 |
| Average True Range (ATR) | 0.15 | 1.13 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 25.35 | 56.46 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.